Coral Omene, MD,PhD

Dr. Omene is the Program Director, Breast Cancer Disparities Research and a medical oncologist with a passion for women’s health dedicated to the care of a diverse pool of breast cancer patients. She believes clinical trials are an important tool to improve patient outcomes and routinely discusses clinical trial options with her patients. She obtained an MD/PhD degree at Columbia University College of Physicians and Surgeons, followed by an Internal Medicine residency at New York Presbyterian Hospital-Columbia University Medical Center. During residency, she studied triple negative breast cancer (TNBC) and the lack of effective therapies. After residency, she pursued a fellowship at NYU School of Medicine, in the field of Hematology/Oncology, with a special interest in breast cancer. At NYU, she continued her pursuit in combining clinical and research training and was the first recipient to receive the Breast Cancer Research Fellowship at NYU Langone Medical Center. She studies the impact of obesity in breast cancer patients, including biological changes, recurrence, and interventional strategies. Research includes changes in response to neoadjuvant chemotherapy in Black women with TNBC and the interplay with obesity, and investigator initiated clinical trials for drug induced weight loss intervention in obese breast cancer patients. Dr. Omene is the Principal Investigator for multiple clinical trials. She serves as Co-chair of the Big Teen Cancer Research Consortium, Breast Cancer Clinical Trial Working Group and the Diversity Committee. She participates in the American Society of Clinical Oncology, American Association for Cancer Research, and the San Antonio Breast Cancer Symposium.

Clinical Interests:

Breast cancer, triple negative breast cancer, translational research, clinical trials